Baker Bros. Advisors’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Hold |
|
|||||
|
2025
Q1 | $7.73M | Hold |
|
|||||
|
2024
Q4 | $9.54M | Hold |
|
|||||
|
2024
Q3 | $8.19M | Hold |
|
|||||
|
2024
Q2 | $8.25M | Hold |
|
|||||
|
2024
Q1 | $22.5M | Hold |
|
|||||
|
2023
Q4 | $23.6M | Buy |
|
|||||
|
2023
Q3 | $18.8M | Hold |
|
|||||
|
2023
Q2 | $26.6M | Hold |
|
|||||
|
2023
Q1 | $20.4M | Hold |
|
|||||
|
2022
Q4 | $27.4M | Hold |
|
|||||
|
2022
Q3 | $48.7M | Hold |
|
|||||
|
2022
Q2 | $21.6M | Hold |
|
|||||
|
2022
Q1 | $32.3M | Hold |
|
|||||
|
2021
Q4 | $52.2M | Hold |
|
|||||
|
2021
Q3 | $66.6M | Hold |
|
|||||
|
2021
Q2 | $85.3M | Buy |
|